Jane Sarashon

JULY 18, 2024

Following the BLS report on the CPI for June 2024, PwC published their new annual report from PwC titled Behind the Numbers 2025 tells us that commercial health care spending is expected to grow some 8.0% (Motor vehicle insurance costs grew a whopping 19.5% in the report, FYI). for Group plans and 7.5% and 7.0%, respectively.

Doctors 59

Doctors Prescription Drug Pricing Hospitals Health Insurance 59

Innovaare Compliance

JUNE 28, 2024

The upcoming Medicare Prescription Payment Plan (M3P), set to launch in January 2025, marks a significant shift in Medicare’s approach to prescription drug coverage. These requirements include: Detailed Reporting: Plans must submit comprehensive data on prescription drug pricing, utilization, and patient outcomes.

Medicare 94

Medicare Medicare Prescription Drug Pricing Compliance 94

Health Populi

OCTOBER 14, 2024

For Tier 3, only applicable to plans with three or more tiers, the average copay is $65 and coinsurance 35%; and, For Tier 4, again for plans with 3 or more tiers, the average copay is $128 and coinsurance a 33% share (generally applicable to specialty drugs).

Health Insurance 62

Health Insurance Prescription Drug Pricing COVID-19 Governance 62

Innovaare Compliance

JUNE 27, 2024

The upcoming Medicare Prescription Payment Plan (M3P), set to launch in January 2025, marks a significant shift in Medicare’s approach to prescription drug coverage. These requirements include: Detailed Reporting: Plans must submit comprehensive data on prescription drug pricing, utilization, and patient outcomes.

Medicare 52

Medicare Medicare Compliance Prescription Drug Pricing 52

Healthcare Law Blog

FEBRUARY 22, 2023

All rebate payments will be deposited into the Medicare Prescription Drug Account in the Federal Supplementary Medical Insurance Trust Fund. September 20, 2025 The date by which CMS must invoice manufacturers for the Part B inflation rebates owed for calendar quarters in 2023 and 2024.

Medicare 52

Medicare Medicare Medicaid Medicaid 52

Health Populi

APRIL 30, 2021

Spending on medicines, globally, will rebound this year and rise above pre-pandemic levels through 2025. Between 2021 and 2025, the annual growth global growth rate for prescription drugs spending is expected to range from 3% to 6%, a $1.6 As such, the debate on prescription drug pricing in the U.S.

COVID-19 62

COVID-19 Prescription Drug Pricing Medicare Medicare 62

Hall Render

MAY 10, 2024

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ Dallas Home Health Company to Pay $4.7

Nursing Homes 40

Nursing Homes Nurses Hospitals Medicaid 40